Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$32.4 - $68.18 $606,528 - $1.28 Million
18,720 New
18,720 $1.28 Million
Q1 2022

May 16, 2022

SELL
$25.68 - $35.59 $182,096 - $252,368
-7,091 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$24.9 - $40.26 $176,565 - $285,483
7,091 New
7,091 $208,000
Q3 2021

Nov 15, 2021

SELL
$25.48 - $37.34 $333,278 - $488,407
-13,080 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$32.46 - $43.42 $240,074 - $321,134
7,396 Added 130.12%
13,080 $428,000
Q1 2021

May 17, 2021

SELL
$38.94 - $50.85 $24,493 - $31,984
-629 Reduced 9.96%
5,684 $232,000
Q4 2020

Feb 16, 2021

BUY
$37.65 - $63.77 $12,763 - $21,618
339 Added 5.67%
6,313 $271,000
Q3 2020

Nov 16, 2020

SELL
$52.76 - $74.49 $1.55 Million - $2.19 Million
-29,370 Reduced 83.1%
5,974 $326,000
Q2 2020

Aug 17, 2020

SELL
$48.73 - $81.82 $158,616 - $266,324
-3,255 Reduced 8.43%
35,344 $2.23 Million
Q1 2020

May 15, 2020

BUY
$41.72 - $87.2 $775,825 - $1.62 Million
18,596 Added 92.97%
38,599 $1.97 Million
Q4 2019

Feb 14, 2020

BUY
$45.7 - $81.86 $199,252 - $356,909
4,360 Added 27.87%
20,003 $1.59 Million
Q3 2019

Nov 14, 2019

BUY
$45.35 - $57.91 $173,962 - $222,142
3,836 Added 32.49%
15,643 $759,000
Q2 2019

Aug 14, 2019

BUY
$52.6 - $63.29 $621,048 - $747,265
11,807 New
11,807 $621,000
Q1 2019

May 14, 2019

SELL
$39.99 - $53.48 $335,516 - $448,697
-8,390 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$31.54 - $46.67 $360,060 - $532,784
-11,416 Reduced 57.64%
8,390 $344,000
Q3 2018

Nov 15, 2018

BUY
$38.0 - $51.1 $26,524 - $35,667
698 Added 3.65%
19,806 $753,000
Q2 2018

Aug 14, 2018

SELL
$38.7 - $50.15 $303,988 - $393,928
-7,855 Reduced 29.13%
19,108 $864,000
Q1 2018

May 15, 2018

BUY
$39.6 - $65.9 $217,285 - $361,593
5,487 Added 25.55%
26,963 $1.3 Million
Q4 2017

Feb 14, 2018

BUY
$29.7 - $45.7 $129,551 - $199,343
4,362 Added 25.49%
21,476 $845,000
Q3 2017

Nov 14, 2017

BUY
$25.1 - $31.05 $429,561 - $531,389
17,114
17,114 $531,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.